Papers
1
Total Citations
14
H-Index
1
About
Haocheng Zheng is a rising leader in hepatobiliary surgery, whose research centers on advancing minimally invasive techniques for liver cancer treatment. His major contributions lie in comparing the efficacy and safety of robotic versus laparoscopic liver resection for hepatocellular carcinoma (HCC), a critical area where long-term outcome data remain scarce. In his landmark 2024 study, Zheng led a propensity score-matched retrospective cohort analysis of patients treated between 2016 and 2021, providing rigorous evidence that robotic liver resection offers comparable—and in some metrics, superior—outcomes to laparoscopic approaches for HCC. This work has already garnered 14 citations, reflecting its immediate impact on surgical decision-making. By systematically evaluating perioperative safety and oncologic efficacy, Zheng’s research helps clarify the role of robotic surgery in expanding treatment options for liver cancer patients. His findings are particularly valuable for surgeons and oncologists seeking to optimize minimally invasive strategies, and they position him as a key contributor to the evolving evidence base in hepatobiliary oncology.
Research Focus
Key Achievements
Top Papers
- 1